Literature DB >> 3394508

Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon.

J Aman1, L Wranne.   

Abstract

Hypoglycaemia (blood glucose 1.3-2.5 mmol/l) was induced in thirty diabetic children by reduction of their morning meal. Glucagon, 10 or 20 micrograms/kg was then given by intramuscular or subcutaneous injection. Ten min later, all signs of hypoglycaemia had disappeared and blood glucose concentrations increased by 0.7-3.3 mmol/l. Glucagon plasma concentrations at glucose nadir were low, 23 +/- 8 pmol/l, rose to 300 +/- 42 ten min after the injection and reached peak values after another ten min. Later, a slow decrease was noted. No significant difference of blood glucose or plasma glucagon concentrations were found after subcutaneous or intramuscular injections of 20 micrograms/kg. After 10 micrograms/kg, slightly lower increase of blood glucose was seen, but the clinical effect was equally good. Nausea occurred in four children given 20 micrograms/kg. The rise of blood glucose did not correlate to the peak glucagon concentration obtained after the injection but showed significant correlations to the lowest glucose concentration and, inversely, to the concentration of free insulin in blood at glucose nadir. It is concluded that glucagon injections are effective in hypoglycaemia in insulin-treated diabetic children and that the injection of 10-20 micrograms/kg gives long-standing supraphysiological concentrations which make repeated injections unnecessary.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394508     DOI: 10.1111/j.1651-2227.1988.tb10698.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  6 in total

1.  Comparison of intramuscular glucagon and intravenous dextrose in the treatment of hypoglycaemic coma in an accident and emergency department.

Authors:  A W Patrick; A Collier; D A Hepburn; D J Steedman; B F Clarke; C Robertson
Journal:  Arch Emerg Med       Date:  1990-06

2.  Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.

Authors:  P A Bakhtiani; J El Youssef; A K Duell; D L Branigan; P G Jacobs; M R Lasarev; J R Castle; W K Ward
Journal:  J Diabetes Complications       Date:  2014-09-16       Impact factor: 2.852

Review 3.  Management of type 1 diabetes in children and adolescents.

Authors:  Vandana Jain
Journal:  Indian J Pediatr       Date:  2013-10-11       Impact factor: 1.967

4.  Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  E Stenninger; J Aman
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

5.  The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan.

Authors:  Masaaki Matsumoto; Hiroyuki Awano; Yushi Hirota; Masashi Nagai; Ryosuke Bo; Atsuko Matsuoka; Tetsushi Hamaguchi; Takehito Takeuchi; Yasushi Nakagawa; Wataru Ogawa; Kazumoto Iijima
Journal:  Endocrine       Date:  2018-10-26       Impact factor: 3.633

6.  Perioperative management in a patient with type 1 diabetes mellitus who presented severe hypoglycemia during dental implant surgery: a case report.

Authors:  Hajime Shimoda; Tetsu Takahashi
Journal:  BMC Oral Health       Date:  2018-12-07       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.